According to attorney general’s early review of Mylans sales contract with local school system,terms may own included ‘potentially anticompetitive terms’New York attorney general Eric Schneiderman has launched an investigation into Mylan Pharmaceuticals, the maker of EpiPens, or after the company was revealed to own increased the price of its life-saving allergy medication and device by 471% since acquiring it in 2007. Related: EpiPen CEO hiked prices on two dozen products and got a 671% pay raise Related: Mylan to supply EpiPen cost assistance as CEO is asked to testify on price hike Continue reading...
Source: theguardian.com